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Introduction
In recent years, a number ofdifferent ion-selective electrodes for
the measurement ofsodium and potassium have been evaluated
against existing methods of flame photometry with good
agreement between the two methods in terms of precision and
accuracy [1-6].
Recently, another ion-selective electrode instrument has
been introduced--the AM 721 ’Direct dip’ system (Kontron
Instruments Ltd, Campfield Road, St. Albans ALl 5JG,
Hertfordshire, UK). This instrument is able to measure directly
the ion concentration of both sodium and potassium in whole
blood, plasma or urine. This paper reports an evaluation of the
instrument and provides some comparative data with other
systems.
Description of the instrument
The AM 721 consists of four sections--a front panel with
controls and indicators, a front-door assembly, an electrode
chamber area, and a rear panel.
On the front panel are the calibration buttons and visual
displays. The ’normal’ and ’high’ buttons are used for electrical
check, calibration and measurement. Each button is pressed and
released before taking a reading. The LED visual displays for the
results are located above the calibration buttons.
The front-door assembly has a window to permit access to
the electrode chamber area, part of this area being visible
through the window of the front-door assembly.
In the electrode chamber area, the sample in the cup is
vibrated and measured by electrodes with sensor tips. The three
electrodes (a black reference, yellow sodium and red potassium
electrode) are held in the electrode-holder portion of the
electrode lift assembly. The electrode holder is connected by a
shaft to the electrode lifter knob at the top of the instrument.
This knob moves up, through a 30 rotation while up, and down,
moving the electrodes to the right and left positions. When the
knob is midway the electrodes are suspended out of solution.
On the rear panel are four labelled potentiometers; the K +
and Na+ potentiometers adjust the set points for the calibration.
In the right-hand corner of the rear panel is a mode switch
enabling the operator to select ’P’ (whole blood or plasma) by
switching to the lower position, or ’U’ (urine) by switching to the
upper position.
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Operation of the instrument
Samples are added to special disposable trays each of which is
divided up into both a left- and right-hand cavity. The sample
volume of 300 #1 is dispensed into the trays using a special
pipette: the ’Konnpipette’. Both the trays and Konnpipette are
supplied with the AM 721.
A two-point calibration is carried out prior to initial use each
day and after every 15 to 25 analyses. The operator chooses the
mode ofoperation (P or U) as described above; ifU is chosen, the
U indicator will be visible on the front of the instrument.
300 #1 of normal calibrant is dispensed into the right-hand
cavity of the sample tray, and 300/A of high calibrant into the
left-hand tray. Separate calibrants are provided for plasma and
urine.
After inserting the tray into the instrument, the electrodes are
lowered into the normal calibrant, initiating a 15-25 s period of
mixing between the sample and electrode assembly. Once
mixing has stopped, time is allowed for stabilization (about 10 s)
after which the ’normal’ button is pressed and released.
Values are checked on a visual display to ensure that they are
within the required limits. The electrodes are then lowered into
the high calibrant and the process repeated with the high button
pressed and released. If the values are within the required limits
for this calibrant, the electrodes are returned to the normal
calibrant and the process repeated--the values are checked
without pressing the normal button. If calibration is successful,
the operator proceeds to sample measurement. If not, the
process is repeated using fresh calibrants. If this still proves
unsuccessful, the operator is referred to the trouble-shooting
section of the instruction manual.
Sample measurement
Three hundred #1 ofnormal calibrant is placed in the right cavity
of a disposable tray and 300 #1 of sample in the left cavity. The
electrodes are placed in the normal calibrant and after mixing
and stabilization, the normal button pressed. Once the values on
the display have been checked, the electrodes are placed in the
sample and the process repeated.
The results are read directly from the visual display. In the
plasma mode, potassium results are given to two decimal places,
in the urine mode, to one. No decimal places are given for
sodium in either mode.
Once sample measurement is complete, the electrodes are
placed in the normal calibrant, which automatically places theinstrument in a standby mode. The electrodes lose calibration
and may become damaged if left exposed to air.
Special procedures for plasma and urine
In the event ofthere being an insufficient plasma volume (i.e. less
than 300 tl) the operator may use the microsample procedure
which needs only 50/A. The normal and high calibrants, together
with the samples, are diluted one in seven using the microsample
dilutor solution in a test-tube; they are mixed well and then
300 #1 of diluted normal calibrant is placed in the right-hand
cavity of a disposable cup and the sensor tips of the electrodes
placed in this for 15 min to equilibrate. A two-point calibration
is carried out. The diluted sample is then measured and the
results recorded.
A diluted urine mode procedure is also available. A one in
seven dilution is made for the calibrants and samples using a
different diluent to that used for plasma. Otherwise the pro-
cedure for urine is identical to that for plasma.
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by comparing the values obtained for the Ortho Control Urine
One with the manufacturer’s target values.
Whole blood
Blood samples were received in lithium heparin tubes. An
aliquot was taken for analysis on the AM 721 and the sample
then centrifuged in a closed tube at 2500 r.p.m, for 10 min in a
non-thermostatted centrifuge. Plasma was normally measured
on the AM 721 within h of separation.
A recent study has shown the effect ofdifferent conditions of
centrifugation on plasma sodium and potassium [9]. Whereas
centrifugation speed and temperature (20C compared with a
non-thermostatted centrifuge) has no significant effect on the
sodium and potassium content of plasma, the influence of
closure of the centrifuge tube has. Centrifugation in open tubes
may, due to the evaporation of plasma water, increase the
sodium by as much as 1.5 mmol/1 in 10min.
Within-batch precision of the whole blood was made by
repeat analysis of a number of patient samples.
A correlation between whole blood and plasma values was
made in 80 patient samples.
Materials and methods
Plasma
Blood was received in lithium heparin from 117 patients. The
plasma was analysed on both the Technicon SMA 2 by flame
photometry and on the AM 721.
Precision was assessed at three levels using commercial
preparations--Wellcomtrols One, Two and Three (Wellcome
Reagents, Wellcome Research Laboratories, Beckenham, Kent,
UK).
Linearity was assessed using another commercial
preparationHyland Q Pak 2 (Travenol Laboratories,
Lessines, Belgium).
For sodium, this material was reconstituted with 4ml of
distilled water instead ofthe recommended 5 ml in order to give
a sodium value of approximately 190mmol/1. For potassium,
the material was reconstituted with 3 ml distilled water to give a
potassium value of approximately 10mmol/l. Dilutions were
made of the reconstituted preparations to cover the range
10-100 (potassium) and 40-100 (sodium).
Carry-over was assessed by the method of Young and
Gochman [7]. Three successive identical samples with a high
value (H1, H2 and H3) were followed by three successive
identical samples with a low value (L1, L2 and L3). Percentage
carry-over was calculated from the formula:
L1-L3
x 100.
H3-L3
Within-batch precision of the microsample procedure was
assessed at three levels using patient samples, one with a high,
one with a normal and one with a low level of sodium and
potassium.
Results and discussion
Plasma
Precision
Both the within- and between-batch precision data for the
instrument are shown in table 1. Between-batch precision gave
coefficients of variation below 1 for sodium and below 2o for
potassium at all levels. Over the same period ofevaluation as the
AM 721, the Technicon control material run on the SMA 2 gave
comparable between-batch coefficients of variation of 0.65
for sodium at a mean level of 148"lmmol/1 and 1"58% for
potassium at a level of 5"6 mmol/1.
Table 1. Precision datafor plasma sodium and potassium
on theAM 721 ion-selective electrode instrument (in mmol/l).
Sodium Potassium
Within- Between- Within- Between-
Control batch batch batch batch
Wellcomtrol One
Number 20 46 20 46
Mean 140"30 140"51 4"72 4"63
SD 0"82 1" 15 0"04 0"08
CV(%) 0.58 0.82 0.85 1.73
Wellcomtrol Two
Number 20 44 20 44
Mean 145.40 146"84 5"54 5"52
SD 0"97 1.23 0"07 0"07
CV (%) 0"67 0"84 1"26 1"27
Wellcomtrol Three
Number 20 45 20 45
Mean 131.30 130"47 3.99 3"96
SD 0"48 1"24 0"03 0"06
CV (%) 0"37 0"95 0.75 1.52
Urine
Within- and between-batch-precision was assessed using Ortho
Control Urine One (Ortho Diagnostic Systems, Raritan, New
Jersey, USA).
Accuracy was assessed by comparing the results obtained on
the AM 721 with those by a routine flame photometer method
on a Technicon AA 2 system for 60 patient specimens. All urines
were aliquots of24 h collections in bottles containing thymol as
preservative. An independent assessment ofaccuracy was made
Accuracy
Figures and 2 show the results for 117 patient plasmas
analysed on both instruments. Potassium results on theAM 721
were corrected to one decimal place to directly compare them
with those obtained by.routine analysis.
The correlation coefficients for sodium and potassium were
0.95 and 0.97 respectively. Sodium gave results which were on
average 1.85mmol/1 lower, potassium results on average
0.16mmol/1 higher than those obtained by routine flame
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Figure 1. Comparison of results obtained in 117 patient
samples by theAM 721 andflame photometry on theSMA 2
for plasma sodium, r=0"95, y=1"O3X-5"9 (where y=AM
721 value, x=SMA 2 value, units are mmol/l).
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photometry. The lower sodium results are in contrast to those
reported on other ion-selective electrodes, where, in general,
sodium was found to produce results which were higher than by
flame photometry [2-6]. The higher potassium results on the
AM 721 are in agreement with results obtained on other
instruments [2-6].
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It has recently been suggested that laboratories should
determine their own correlation between their flame photometer
and ion-selective electrode results and correct the ion-selective
electrode values to those obtained by flame photometry [8]. An
alternative approach might be to obtain a different reference
range for the ion-selective electrodes.
A further assessment of accuracy was made by comparing
the overall mean values obtained using Wellcomtrols One and
Three with target values quoted by the manufacturer for ion-
selective electrode methodology. (No value was quoted for
Wellcomtrol Two.) The comparison is shown in table 2. Values
obtained on the AM 721 agreed well with the target values.
Table 2. Comparison ofthe results obtained on theAM 721
with the target values quoted by the manufacturer for ion-
selective methodology (in mmol/1).
Sodium Potassium
Control AM 721 Target AM 721 Target
Wellcomtrol One 140.50 139.90 4.63 4.81
Wellcomtrol Three 130.47 131.0 3.96 3.95
Linearity
Linearity data for sodium and potassium are shown in figures 3
and 4 respectively. Linearity for sodium was found to fall off
below 90mmol/1; potassium was found to be linear between
and 10mmol/l. The range was greater than that quoted for the
Orion SS 30 analyser for both sodium and potassium I-3] and the
upper limit of the range for potassium was greater than that
found on the Nova [6].
Carry-over
The mean carry-over, which was assessed on three occasions,
was found to be 0.6 for sodium and 0.4 for potassium.
Precision of the microsample procedure
Within-batch precision data at three levels of sodium and
potassium are given in table 3. These figures were obtained using
enough diluted normal calibrant for both the calibration and
precision study.
Urine
Initial studies using the undiluted urine mode showed some
large discrepancies between results obtained on theAM 721 and
by routine flame photometry. This was particularly evident for
potassium; values for the control urine were close to the target
values. The control was reconstituted in distilled water and the
urine samples were collected in thymol. The instruction manual
states that certain preservatives may affect the performance of
the electrodes, but this statement is not elaborated. The problem
was solved by using the diluted urine procedure.
Precision
The within-batch and between-batch precision data for the
diluted urine mode are shown in table 4. Normal calibrant was
diluted in bulk for the purpose ofthe within-batch study and for
each batch ofpatient or between-batch quality-control samples.
Between-batch precision data obtained over the same period
of evaluation as the AM 721 by the routine flame photometer
method using a pooled control urine gave a CV of 2.33 for
sodium (a mean of 125.9mmol/1) and 2"52 for potassium (a
mean of61,2 mmol/1). The slightly higher figures for theAM 721
may in part be due to the manual dilution step prior to analysis.200
180-
160
140
120
I00
80"
i’
40 60 80 I00
Percentoge dilution of control
Figure 3. Linearity data for plasma sodium. The y axis
9ires the value in mmol/1, the x axis the dilution of the
control material, rangin9 from 40 to 100%.
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Figure 4. Linearity datafor plasma potassium. The y axis
.qives the value in mmol/l, the x axis, the dilution of the
control material, ranyin9 from 10 to 100%.
Table 4. Precision data for urine sodium and potassium.
These data were obtained usin9 the diluted urine mode
procedure (in mmol/l).
Sodium Potassium Sodium Potassium
Within- Within- Between- Between-
batch batch batch batch
Number 20 20 20 20
Mean 90"84 36"42 89"28 35.35
SD 0’76 0"58 2.27 1.34
CV () 0.84 1.60 2.54 3.79
Table 3. Within-batch precision for plasma sodium and
potassium usin9 the special microsample dilution procedure
(in mmol/1).
Sodium Potassium
Low level
Number 20 20
Mean 120.18 2"56
SD 1.94 0"06
CV (%) 1.61 2’34
Normal level
Number 20 20
Mean 136.33 3.65
SD 0.71 0.05
CV (o) 0.52 1.37
High level
Number 20 20
Mean 150.17 5.32
SD 1.72 0.08
CV (%) 1.15 1.50
Accuracy
Figures 5 and 6 show the results for 60 urine samples analysed on
both instruments. Potassium results were taken to the nearest
whole number to directly compare them with those obtained by
routine analysis. The correlation coefficients for sodium and
potassium were 0.99 and 0.98 respectively. Sodium produced
results on the AM 721 which were on average 0’5 mmol/1 lower
than flame photometry; potassium results were on average
2.6 mmol/1 lower than those obtained by flame photometry. A
similar finding ofa greater discrepancy for potassium was found
on the Nova [6].
An independent assessment of accuracy was made by
comparing results obtained for the control urine with the target
value quoted by the manufacturer for the control material.
Unlike the Wellcomtrols, no target value was quoted for ion-
selective electrode methodology, so a comparison was made of
values quoted for the SMA 6/60 flame photometer method. The
overall mean value for sodium (89.28) was 1.5 higher, and the
potassium value (35.35) was 1 lower than the target value
quoted.
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Figure 5. Comparison of results obtained in 60 patient
samples by the AM 721 andflame photometry on the AA 2
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for urine sodium, r=0"99, y= 1.02 x -2.2 (wher.e y=AM
721 value, x AA 2 value, units are mmol/1).
Table 5. Within-batch precision datafor the whole blood
modefor seven patient samples. Each sample was analysed
10 times (in mmol/l).
Sodium Potassium
Mean SD CV () Mean SD CV (%)
141"40 0"70 0"50 3’74 0"05 1.34
138.90 0’57 0.41 5.10 0.06 1.18
112.20 1.47 1.31 2"38 0.04 1.68
135’56 0.52 0.38 3’31 0"03 0.91
141.00 0 0 4.15 0.05 1.20
142.30 0’82 0"5 5.61 0"06 1.07
124.20 0.44 0"35 4.37 0.05 1.14
Table 6. Data obtained in 80 samples comparing whole
blood and plasma measurements (y=plasma value and
x=whole blood value). The mean whole blood value
(mmol/1) refers to the bias found in blood when compared
with measurement in ,plasma.
Mean whole
Correlation Equation of the blood value
Analyte coefficient line of best fit (mmol/1)
Sodium 0"96 y=0’95 x+6.91 -0.15
Potassium 0’98 y=0"99 x +0.02 +0.01
I00
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Figure 6. Comparison of results obtained in 60 patient
samples by the AM 721 andflame photometry on the AA 2
for urine potassium, r=0"98, y=1"O6X-5"O (where
y=AM 721 value, x AA 2 value, units are mmol/1).
Whole blood
Precision
Within-batch precision for whole blood for seven patient
samples is shown in table 5. Each figure represents the mean of
10 analyses.
Comparison with plasma
The results for 80 patient samples comparing the whole blood
and corresponding plasmas are given in table 6. The potassium
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results were taken to one decimal place. The overall correlation
coefficients for sodium and potassium were 0"96 and 0"98
respectively.
The range of values covered in whole blood for sodium was
112 to 145 mmol/l, and 2.6 to 5"6 mmol/1 for potassium. Sodium
results in whole blood were, on average, 0.15 mmol/l lower than
those found in plasma (mean whole blood sodium
135.11 mmol/1, mean plasma sodium 135.26 mmol/1). Potassium
results in whole blood were, on average, 0’01 mmol/1 higher than
those found in plasma (mean whole blood potassium
3"94 mmol/1, mean plasma potassium 3"93 mmol/1). From the
results, comparing whole blood and plasma, it seems probable
that no separate reference range needs to be established for
whole blood sodium and potassium.
The design ofthe reference electrode has been shown to be an
important factor in determining whether differences between
whole blood and plasma are significant or not [9].
General comments
Instruction manual
The manual provided with theAM 721 was simple to follow.It is
divided into several sections including ones on how to adjust the
potentiometer set points and trouble-shooting (problem-
solving). The trouble-shooting section lists four groups of
problems which might be encountered. These are listed in the
approximate order in which they would occur in going from
installation to calibration to sample measurement. The prob-
lems are analysed in two columns, based on whether the problem
is shown by both the sodium and potassium electrode or by only
one ofthe electrodes. Each column lists the common causes and
solutions.
The comment at the beginning ofthe manual on the possible
effect of urine preservatives on the electrode performance was
found to be relevant in the present study, and could have been
usefully restated in the section on urine measurement. Eachlaboratory should evaluate the effect of their urine preservative
(if one is used) on the performance of the electrodes before
proceeding with this mode.
Costs
The approximate cost of the instrument at the time of the
evaluation was 2430 plus value-added tax. The reference and
sodium electrodes cost approximately 110 each, the potassium
electrode 70; a boxed set ofall three electrodes is priced at 230.
The disposable cups, supplied in batches of 300, are around
0.05 each. It is possible to reuse them by soaking overnight in
decon solution, followed by rinsing in water and drying in the
oven prior to reuse, and this can bring down cost per test by a
considerable amount. The normal and high calibrants for
plasma and whole blood are supplied in bottles of 58 ml each at
around 12.00 per bottle. Urine calibrants and one bottle of
urine dilutor solution come as a set, each set costing about
12"00 (each of the three bottles contains l18ml of solution).
The microsample dilutor solution is supplied in a box, each box
containing two 118 ml bottles.
General conclusions
The instrument was found to be simple to operate with results
obtainable within 70-75 ofstarting to sample the calibrant and
specimen.
The visual display on the instrument was clear and generally
easy to read--it was difficult in bright sunlight.
The lifetime of the sodium electrode is claimed to be four
years and the potassium electrode is one year. The lifetime
depends to some extent on adequate maintenance of the
electrode system. Daily cleaning in a solution of 0.1 M am-
monium bifluoride is recommended--this solution is provided
with the instrument.
The instrument shares with similar systems the advantage of
safety over flame photometry, as no gas or compressed air
supply is required. A.dditional advantages which the author feels
the instrument has over other systems include the size of the
instrument and the volume of sample required for assay. The
AM 721 weighs only 5 kg and its dimensions are 28 cm in height
and 25 cm in width. Comparable figures for one other instru-
ment, the Nova 1, are 43 kg weight, 48.4 cm height and 39.4 cm
width. Size can often be an important factor in a clinical
chemistry laboratory where space may not be readily available.
An insufficient volume of plasma (i.e. less than 300 #1) may be
encountered, especially in paediatric samples. Here, the operator
may use the special microsample procedure requiring only 50 #1;
the Orion SS 30 uses 500#1 of plasma and the Nova needs
180/A. The instrument would be most useful as an out-of-hours
sodium and potassium analyser for clinical chemistry labora-
tories. It could also find a home in intensive-care units, surgical
and renal units, or out-patient departments where urgent results
may be needed.
A minimum of skill is needed to operate the instrument. The
study has shown that there is good agreement between whole
blood and plasma. Therefore in units where a centrifuge is not
always available, whole blood analysis can be performed (the
only requirement being a source of electricity).
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Principal Biochemist, North Middlesex Hospital for helpful
comments on the paper; Dr Gerald Levin, Senior Lecturer in
Chemical Pathology, St. George’s Hospital Medical School for
arranging for the diagrams to be drawn and Miss Deborah
Young for typing the script.
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IUPAC 1985
The 30th International Congress of Pure and
Applied Chemistry
The 30th IUPAC Congress will be held from Monday
9 to Friday 13 September 1985 in Manchester, UK. The
opening ceremony and the inaugural plenary lecture
will take place on Monday morning; the meeting will
end at lunchtime on Friday. A full programme of
evening and daytime social events is being planned.
The Royal Society of Chemistry is responsible for
the detailed organization of the Congress.
Prominent chemists from all over the world are being
invited to present lectures. The symposia within the
individual sections will take place both concurrently
and sequentially. It is planned to include free-offer
contributions, particularly as posters. Details regard-
ing submission of papers will be notified in a circular,
which will be available in March 1984.
Requests to be added to the mailing listfor circulars to
the Royal Society of Chemistry, Burlington House,
London W1 V OBN.
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